Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes

Inclusion Criteria:

• Type 1 diabetes for at least 12 months

• Current treatment with any basal/bolus regimen or any biphasic insulin treatment forat least 6 months

• BMI below or equal to 35 kg/m^2

• HbA1c below or equal to 12%

Exclusion Criteria:

• Proliferative retinopathy or maculopathy requiring acute treatment

• Recurrent major hypoglycaemia that may interfere with trial participation (as judgedby the Investigator)

• Subjects with known hypoglycaemic unawareness as judged by the Investigator